Cluster headache microRNA study
Part of Brain & nervous system, Pain clinical trials.
This study aims to understand how certain tiny molecules in the blood (called microRNAs) are different in people with cluster headache. It could help find better ways to diagnose or treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with episodic or chronic cluster headache for at least one year.
- You do not have any other headache disorder (like migraine or frequent tension headaches).
- You do not have other neurological conditions or chronic pain syndromes.
- You are not pregnant or breastfeeding, and you have not used painkillers (NSAIDs, triptans, or opioids) in the last 24 hours.
- You are not using substances of abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with certain severe headache disorders (cluster-type headaches or SUNCT/SUNA) or trigeminal neuralgia (sharp facial nerve pain). Researchers want to better understand these conditions and see how study testing/record review may help care.
This study tracks the daily experiences of people with cluster headaches. It aims to better understand your symptoms and how they affect your life.
This trial tests whether injections of botulinum toxin type A can reduce frequent, severe cluster headache attacks by targeting a facial nerve area. It’s for people whose cluster headaches have not responded well—or have caused side effects—to standard preventive treatments.
This study looks at measurable “pain signals” (biomarkers) in people with certain headache disorders or lumbar nerve pain, and compares them with healthy people. It may help researchers better understand what drives pain and how it can be detected.
This study tests if a combination of pulsed radiofrequency and platelet-rich plasma can help people with episodic cluster headaches feel better during a cluster period. It is for people whose headaches are not well controlled with standard medicines.
This study is a registry, meaning it collects information over time about people with headaches (including migraine, tension-type, and some dizziness-related headaches). It may help researchers better understand these conditions and plan future studies.
Hear when a new Cluster Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.